By Antibody Types
By Purification Methods
By End-Users
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antibody Purification Services Market Snapshot
Chapter 4. Global Antibody Purification Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Antibody Types, Estimates & Trend Analysis
5.1. By Antibody Types, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following By Antibody Types:
5.2.1. Monoclonal
5.2.2. Polyclonal
Chapter 6. Market Segmentation 2: By Purification Methods Estimates & Trend Analysis
6.1. By Purification Methods & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following By Purification Methods:
6.2.1. Physio Chemical
6.2.2. Class Specific
6.2.3. Antigen Affinity Purification
6.2.4. Other Methods
Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following By End-Users:
7.2.1. Hospitals and Clinics
7.2.2. Industry and Research Institutes
Chapter 8. Antibody Purification Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Antibody Purification Services Market revenue (US$ Million) estimates and forecasts By Antibody Types, 2021 & 2034
8.1.2. North America Antibody Purification Services Market revenue (US$ Million) estimates and forecasts By Purification Methods, 2021 & 2034
8.1.3. North America Antibody Purification Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2021 & 2034
8.1.4. North America Antibody Purification Services Market revenue (US$ Million) estimates and forecasts by country, 2021 & 2034
8.2. Europe
8.2.1. Europe Antibody Purification Services Market revenue (US$ Million) By Antibody Types, 2021 & 2034
8.2.2. Europe Antibody Purification Services Market revenue (US$ Million) By Purification Methods, 2021 & 2034
8.2.3. Europe Antibody Purification Services Market revenue (US$ Million) By End-Users, 2021 & 2034
8.2.4. Europe Antibody Purification Services Market revenue (US$ Million) by country, 2021 & 2034
8.3. Asia Pacific
8.3.1. Asia Pacific Antibody Purification Services Market revenue (US$ Million) By Antibody Types, 2021 & 2034
8.3.2. Asia Pacific Antibody Purification Services Market revenue (US$ Million) By Purification Methods, 2021 & 2034
8.3.3. Asia Pacific Antibody Purification Services Market revenue (US$ Million) By End-Users, 2021 & 2034
8.3.4. Asia Pacific Antibody Purification Services Market revenue (US$ Million) by country, 2021 & 2034
8.4. Latin America
8.4.1. Latin America Antibody Purification Services Market revenue (US$ Million) By Antibody Types, (US$ Million)
8.4.2. Latin America Antibody Purification Services Market revenue (US$ Million) By Purification Methods, (US$ Million)
8.4.3. Latin America Antibody Purification Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Antibody Purification Services Market revenue (US$ Million) by country, (US$ Million) 2021 & 2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Antibody Purification Services Market revenue (US$ Million) By Antibody Types, (US$ Million)
8.5.2. Middle East & Africa Antibody Purification Services Market revenue (US$ Million) By Purification Methods, (US$ Million)
8.5.3. Middle East & Africa Antibody Purification Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Antibody Purification Services Market revenue (US$ Million) by country, (US$ Million) 2021 & 2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Antibody Research Corporation
9.2.2. Bio-synthesis Inc
9.2.3. BBI Solutions
9.2.4. SouthernBiotech
9.2.5. Thermo Fisher Scientific
9.2.6. Virusys Corporation
9.2.7. RD Biotech
9.2.8. Detai Bio-tech Co.
9.2.9. Genscript
9.2.10. KMD Bioscience
9.2.11. Southern Biotech
9.2.12. GE healthcare
9.2.13. COVALAB
9.2.14. Envigo
9.2.15. Rockland
9.2.16. Creative Biolabs
9.2.17. Abcam
9.2.18. BBI Solutions
9.2.19. Karebay Bio
9.2.20. HuaBio
9.2.21. Antibodies Inc
9.2.22. ProSci Incorporated
9.2.23. ProteoGenix
9.2.24. Genway Biotech, Inc.
9.2.25. Covance Inc.
9.2.26. Sino Biological Inc.
9.2.27. Kaneka Eurogentec S.A.
9.2.28. Takara Bio Inc.
9.2.29. Other Prominent Player
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.